Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Stagg

Showing results (11-20 of 108) with videos related to

Pageof 11
Sort By:
Immunology and Cell Biology|February 9, 2017
Targeting A2 adenosine receptors in cancerDavid Allard, Martin Turcotte, John Stagg
Journal for Immunotherapy of Cancer|February 27, 2020
On the mechanism of anti-CD39 immune checkpoint therapyDavid Allard, Bertrand Allard, John Stagg
Methods in Molecular Biology (Clifton, N.J.)|November 12, 2022
Optimal CCN4 Immunofluorescence for Tissue MicroarrayPierre-Olivier Gaudreau, Isabelle Cousineau, John Stagg
Cancer Treatment Reviews|April 7, 2015
Role of CD154 in cancer pathogenesis and immunotherapyGhada S Hassan, John Stagg, Walid Mourad
Frontiers in Immunology|March 7, 2014
The Role of Ectonucleotidases CD39 and CD73 and Adenosine Signaling in Solid Organ TransplantationVeena Roberts, John Stagg, Karen M Dwyer
Blood|November 19, 2005
Interferon-gamma-stimulated marrow stromal cells: a new type of nonhematopoietic antigen-presenting cellJohn Stagg, Sandra Pommey, Nicoletta Eliopoulos, et al.
Seminars in Immunology|October 13, 2019
Targeting the adenosine pathway for cancer immunotherapyAkil Hammami, David Allard, Bertrand Allard, et al.
Human Gene Therapy|June 24, 2004
Marrow stromal cells for interleukin-2 delivery in cancer immunotherapyJohn Stagg, Laurence Lejeune, André Paquin, et al.
Methods in Enzymology|November 16, 2019
Measurement of CD73 enzymatic activity using luminescence-based and colorimetric assaysBertrand Allard, Isabelle Cousineau, Kathleen Spring, et al.
Nature Reviews. Clinical Oncology|July 19, 2020
Publisher Correction: The adenosine pathway in immuno-oncologyBertrand Allard, David Allard, Laurence Buisseret, et al.
Pageof 11

Showing results (11-20 of 108) with videos related to

Sort By:
Pageof 11
Immunology and Cell Biology|February 9, 2017
Targeting A2 adenosine receptors in cancerDavid Allard, Martin Turcotte, John Stagg
Journal for Immunotherapy of Cancer|February 27, 2020
On the mechanism of anti-CD39 immune checkpoint therapyDavid Allard, Bertrand Allard, John Stagg
Methods in Molecular Biology (Clifton, N.J.)|November 12, 2022
Optimal CCN4 Immunofluorescence for Tissue MicroarrayPierre-Olivier Gaudreau, Isabelle Cousineau, John Stagg
Cancer Treatment Reviews|April 7, 2015
Role of CD154 in cancer pathogenesis and immunotherapyGhada S Hassan, John Stagg, Walid Mourad
Frontiers in Immunology|March 7, 2014
The Role of Ectonucleotidases CD39 and CD73 and Adenosine Signaling in Solid Organ TransplantationVeena Roberts, John Stagg, Karen M Dwyer
Blood|November 19, 2005
Interferon-gamma-stimulated marrow stromal cells: a new type of nonhematopoietic antigen-presenting cellJohn Stagg, Sandra Pommey, Nicoletta Eliopoulos, et al.
Seminars in Immunology|October 13, 2019
Targeting the adenosine pathway for cancer immunotherapyAkil Hammami, David Allard, Bertrand Allard, et al.
Human Gene Therapy|June 24, 2004
Marrow stromal cells for interleukin-2 delivery in cancer immunotherapyJohn Stagg, Laurence Lejeune, André Paquin, et al.
Methods in Enzymology|November 16, 2019
Measurement of CD73 enzymatic activity using luminescence-based and colorimetric assaysBertrand Allard, Isabelle Cousineau, Kathleen Spring, et al.
Nature Reviews. Clinical Oncology|July 19, 2020
Publisher Correction: The adenosine pathway in immuno-oncologyBertrand Allard, David Allard, Laurence Buisseret, et al.
Pageof 11